ALEMTUZUMAB

UNII:	3A189DH42V
Formula:
Preferred Substance Name:	ALEMTUZUMAB

216503-57-0
ALEMTUZUMAB (GENETICAL RECOMBINATION)
ALEMTUZUMAB (GENETICAL RECOMBINATION) [JAN]
ALEMTUZUMAB [EMA EPAR]
ALEMTUZUMAB [INN]
ALEMTUZUMAB [JAN]
ALEMTUZUMAB [MART.]
ALEMTUZUMAB [MI]
ALEMTUZUMAB [PURPLE BOOK CDER]
ALEMTUZUMAB [USAN]
ALEMTUZUMAB [VANDF]
ALEMTUZUMAB [WHO-DD]
ALLO 647 [WHO-DD]
CAMPATH-1H
GZ402673
GZ-402673
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULPHIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD52 (ANTIGEN)) (HUMAN-RAT MONOCLONAL CAMPATH-1H, .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD52 (ANTIGEN)) (HUMAN-RAT MONOCLONAL CAMPATH-1H, .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
LDP-03
LEMTRADA
RECOMBINANT HUMANISED IGG1 KAPPA ANTI-CD52 MONOCLONAL ANTIBODY ALLO-647

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ALEMTUZUMAB

Synonyms and Mappings

Resources